Categories: News

CHOWIS to Develop Customized Cosmetics Diagnostic Platform in Partnership With Kolmar Korea

Chowis Co. Ltd. Skin, Hair and Scalp Solutions Provider Signs Agreement with Kolmar Korea to Develop AI driven Skin Analysis Platform.

SEOUL, SOUTH KOREA / ACCESSWIRE / July 3, 2024 / Chowis Co. Ltd., a leading provider of AI skin diagnostic solutions in South Korea, has entered into a strategic partnership with Kolmar Korea to develop an advanced customized cosmetics diagnostic platform.

Chowis – Kolmar Korea
Chowis – Kolmar Korea

On May 29th, the collaboration was formalized through a Memorandum of Understanding (MOU) signed at Kolmar Korea’s R&D Complex in Naegok-dong, Seocho-gu, Seoul. The signing ceremony was attended by Han Sang-geun, Vice President of Korea Kolmar’s Technology Research Institute, and Ryan WS Choi, CEO of Chowis Co., Ltd.

Chowis Co., Ltd. is renowned for its mobile skin, hair, and scalp diagnostic solutions that leverage AI and LED optical technology. Their services include a web-based application that analyzes various skin conditions such as wrinkles, pigmentation, pores, and redness through full-face image captures.

The partnership aims to combine the technological expertise of both companies to develop a customized cosmetics diagnostic platform. Chowis Co., Ltd. will utilize its optical diagnostic technology to assess consumers’ skin conditions, while Kolmar Korea will interpret these analyses to recommend the optimal products tailored to individual skin profiles.

The diagnostic process will allow consumers to capture images of their faces via a beauty company’s website or app. The platform will analyze multiple skin conditions and incorporate a brief questionnaire about the consumers’ usual skin concerns and lifestyle habits. Based on this information, it will recommend personalized cosmetics. Should consumers decide to purchase the suggested products, Kolmar Korea will manufacture them. This initiative aims to support beauty companies in entering the customized cosmetics market by providing them with the diagnostic platform.

“We value promising collaborations such as this with Kolmar Korea. We share a common goal in providing accurate analysis and aligned recommendations to end consumers,” stated Ryan WS Choi, CEO of Chowis Co., Ltd.

Contact Information

Chowis Company
chowis@chowis.com

SOURCE: Chowis

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

3 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

3 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

3 hours ago